Corrigendum to “Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)” [Respir. Med. 170 (Aug-Sep 2020) 106021]
2020; Elsevier BV; Volume: 175; Linguagem: Inglês
10.1016/j.rmed.2020.106186
ISSN1532-3064
AutoresChristian Geßner, Oliver Kornmann, Jorge Máspero, Richard N. van Zyl-Smit, Matthias Krüll, Anna Salina, Pritam Gupta, Sebastien Bostel, Sebastian Fucile, Lorena Garcia Conde, Pascal Pfister,
Tópico(s)Inhalation and Respiratory Drug Delivery
Referência(s)